Research indicates that non-shockable cardiac arrest is associated with higher mortality rates compared to cardiac arrest cases wherein shockable rhythms such as ventricular fibrillation or pulseless ...

Cardiac arrests that can be treated by electric stimulation, also known as shockable arrests, were found at a higher frequency in public settings than in the home, according to a National Institutes ...

For patients with cardiac arrest and a shockable rhythm, automated external defibrillators (AEDs) in private homes improve outcomes but cannot be considered cost-effective at current pricing, ...

COPENHAGEN, Denmark, September 09, 2025--(BUSINESS WIRE)--Neurescue ApS today announced CE Mark approval for the NEURESCUE ® device, the first and only medical device approved to treat non-shockable ...

Lowering the body's temperature in cardiac arrest patients with 'non-shockable' heart rhythms increases survival and brain function. Patients who received the treatment were about three times more ...

Cardiac arrests that can be treated by electric stimulation, also known as shockable arrests, were found at a higher frequency in public settings than in the home, according to a new study. Cardiac ...

Danish medtech company Neurescue has gained a European CE mark for its catheter to address non-shockable cardiac arrest. The company’s catheter is used in conjunction with a handheld control unit to ...

Incremental cost-effectiveness ratio was $4,481,659 per quality-adjusted life-year for AED in a private home. (HealthDay News) — For patients with cardiac arrest and a shockable rhythm, automated ...